Search
for
Sort by
Research 331–360 of 1000+
- Integrated Meta-Analysis of Scalp Transcriptomics and Serum Proteomics Defines Alopecia Areata Subtypes and Core Disease Pathways
- Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
- Novel Quinazoline Derivative Induces Differentiation of Keratinocytes and Enhances Skin Barrier Functions against Th2 Cytokine-Mediated Signaling
- The Immunological Intersection of Psoriasis and Autoimmune Diseases: Shared Pathways and Clinical Implications
- Molecular crosstalk between lncRNA H19, miR-29a, and JAK2/STAT3 signaling in alopecia areata: a preliminary study
- CD34 <sup>+</sup> cell–derived fibroblast-macrophage cross-talk drives limb ischemia recovery through the OSM-ANGPTL signaling axis
- Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Androgens and Parkinson’s disease: the role in humans and in experiment
- Increase in IL-15 levels in patients with alopecia areata
- The role of integrin alphavbeta6 in impaired wound healing and hair follicle regeneration
- Immune cell regulation of the hair cycle
- 681 Inhibition of STAT3, using Oenocarpus bataua vegetable oil, on in vitro model
- Myeloproliferative disorder associated with alopecia universalis
- JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease
- Review of Promising Off-Label Use of Deucravacitinib
- Unexpected Effect of Baricitinib Use: Observation of a Case of Hypertrichosis
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- T <sub>H</sub> 1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata
- Nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of tofacitinib for treating alopecia areata
- S3886 Concurrent Management of Crohn's Ileitis and Alopecia Universalis With Upadacitinib
- Autoinmune Alopecia/Alopecia Areata
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy
- Immune niches for hair follicle development and homeostasis
- Comprehensive single-cell transcriptomic profiling of the scalp from patients with moderate-to-severe alopecia areata
- Keratin 6A promotes skin inflammation through JAK1-STAT3 activation in keratinocytes
- Forsythiasides: A review of the pharmacological effects
- Impact of mTORC1 inhibition on keratinocyte proliferation during skin tumor promotion in wild‐type and BK5.Akt<sup>WT</sup> mice
- Exosome-Based Therapies for Alopecia Areata: A Systematic Review of Clinical and Experimental Evidence